期刊文献+

艾司西酞普兰与帕罗西汀治疗惊恐障碍的比较 被引量:11

Comparison of escitalopram and paroxetine in treatment of panic disorder
下载PDF
导出
摘要 目的探讨艾司西酞普兰对惊恐障碍患者的疗效及不良反应。方法将66例惊恐障碍患者随机分为艾司西酞普兰组和帕罗西汀组,疗程8周,并用汉密顿焦虑量表(HAMA)、汉密顿抑郁量表(HAMD)、抗抑郁药不良反应评定量表(SERS)对患者治疗前后进行评估。结果在治疗的第1周、第2周末艾司西酞普兰组的HAMA分值均低于对照组,而在4、6、8周末,两组患者的HAMA分值差异无统计学意义。在治疗8周末时,艾司西酞普兰组治愈率为64.5%,有效率为90.3%,帕罗西汀组分别为63.3%、90.0%。两组差异无统计学意义。在不良反应方面,两组差异无统计学意义。结论艾司西酞普兰治疗惊恐障碍疗效与帕罗西汀相当,不良反应无明显差异。 Objective: To investigate the chnical efficacy and side effects of escitalopram in treating patients with panic disorder. Methods: Sixty-six patients with panic disorder were randomized divided into two groups. Patients in study group were treated with escitalopram and the control group were treated with paroxetine. All the subjects were rated by Hamilton Rating Scale for Anxiety (HAMA), Hamiton Rating Scale for Depression and Rating Scale for Side Effects (SERS) at the baseline and the end of week one , two, four, six, eight, respectively. Rzesults:Score of HAMA in the study group was significantly lower than that in the control group at the end of the first two weeks, but there were no significant differences between the two groups in both clinical effect and side effects at the end of week 4, 6, 8. The remission and response rates were 64. 5% and 90.3% respectively in the study group at the end of week 8 according to the HAMA score of change. The remission and response rates were 63.3% and 90.0% respectively in paroxetine group, with no statistical difference between the two groups. Conclusion:There is no significant difference betwe escitalopram and paroxetine in treating patients with panic disorder in terms of clinical efficacy and and adverse effects.
作者 蔡敏 沈鑫华
出处 《上海精神医学》 2008年第1期33-35,共3页 Shanghai Archives of Psychiatry
关键词 艾司西酞普兰 帕罗西汀 惊恐障碍 Escitalopram Paroxetine Panic disorder
  • 相关文献

参考文献9

  • 1余常红,胡赤怡.惊恐障碍病人随访研究[J].中国心理卫生杂志,2002,16(9):614-615. 被引量:17
  • 2中华医学会精神科分会.中国精神障碍分类与诊断标准:3版[M].济南:山东科学技术出版社,2001.75-8.
  • 3张明园.精神科量表评定手册[M].长沙:湖南科技出版社,1998.151.
  • 4肖融,吴薇莉,张伟.惊恐障碍的病因学特征[J].中国临床康复,2005,9(48):111-113. 被引量:9
  • 5刘协和,袁德基.牛津精神病学教科书(中文版).成都:四川大学出版社.2004.356.
  • 6Pema G, Bertani A, Caldirola D, et al. A comparison of citalopram and paroxetine in the treatment of panic disorder. A randomized, single - blind study Pharmacopsychiat, 2001,34 : 8 - 91
  • 7Stahl SM,Cergrel I,Li D. Escitalopram in the treatment of panic disorder: a randomized, double - blind, placebo - controlled trial. J Clin Psychiat,2003,64( 11 ) :1322 - 1327
  • 8SanchezC , Bergqvist PB, Brennum LT, et al. Escitalopram, the S - ( + ) - enantiomer of citalopram,is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacol ( Berl ) , 2003, 167 (4) :353 -362
  • 9Kennedy SH, Andersen HF , Law RW. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective seretonin reuptake inhibitors and venlafaxine XR: a meta-analysis. Psychiat Neuresci, 2006,31 (2) : 122 - 131

二级参考文献34

  • 1[1]Mavissakalian M, Perel JM. Clinical experiments in mainten a nce and discontinuation of imipramine therapy inpanic disorder with agoraphobia . Arch Gen Psychiatry 1992 Apr;49(4):318-23.
  • 2[2]John R Walker,G Ron Norton,Colin A Ross.Panic Disorders AND Agoraphob i a,P365. Brooks/Cole Publishing Company Pacific Grove,California 1991..
  • 3[3]Mavissakalian M, Perel JM. Protective effects of imipramine maintenan c e treatment in panic disorder with agoraphobia. Am J Psychiatry 1992 Aug;149(8 ):1053-7.
  • 4[4]Pollack MH, Otto MW, Tesar GE, et al. Long-term outcome after acute t r eatment with alprazolam or clonazepam for panic disorder.J Clin Psychopharmacol 1993 Aug;13(4):257-63.
  • 5[5]Keller MB, Hanks DL. Course and outcome in panic disorder.Prog Neuro psychopharmacol Biol Psychiatry 1993 Jul;17(4):551-70.
  • 6[6]Papp LA, Schneier FR, Fyer AJ,et al. Clomipramine treatment of panic disorder: pros and cons.J Clin Psychiatry 1997 Oct;58(10):423-5.
  • 7[7]Emmanuel NP, Ware MR, Brawman-Mintzer O,et al. Once-weekly dosing of f luoxetine in the maintenance of remission in panic disorder.J Clin Psychiatry 1999 May;60(5):299-301.
  • 8[8]Curtis GC, Massana J, Udina C, et al; Maintenance drug therapy of pani c disorder.J Psychiatr Res 1993;27 Suppl 1:127-42.
  • 9[9]Liebowitz MR. Panic disorder as a chronic illness.J Clin Psychiatry 1997;58 Suppl 13:5-8.
  • 10[10]Spiegel DA, Bruce TJ, Gregg SF, et al, Does cognitive behavior therap y assist slow-taper alprazolam discontinuation in panic disorder? Am J Psychiatr y 1994 Jun;151(6):876-81.

共引文献55

同被引文献100

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部